626012950	626012950	CD	B-NP	O
|	|	NN	I-NP	O
EH	EH	NN	I-NP	O
|	|	NN	I-NP	O
41614963	41614963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1039762	1039762	CD	B-NP	O
|	|	CC	I-NP	O
7/19/2006	7/19/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/17/2006	9/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/8/2006	10/8/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MERKERSON	MERKERSON	NNP	B-NP	O
,	,	,	O	O
PRESTON	PRESTON	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
KRLH	KRLH	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiomyopathy	Cardiomyopathy	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Bile	Bile	NN	B-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Esophagogastroduodenoscopy	Esophagogastroduodenoscopy	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EGD	EGD	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Open	Open	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ERCP	ERCP	NN	B-NP	B-protein
with	with	IN	B-PP	O
biliary	biliary	JJ	B-NP	O
stenting	stenting	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
46-year-old	46-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
for	for	IN	B-PP	O
familial	familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
after	after	IN	B-PP	O
dinner	dinner	NN	B-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
nonbilious	nonbilious	JJ	B-NP	O
emesis	emesis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
and	and	CC	O	O
flatus	flatu	VBZ	B-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
fevers	fever	NNS	B-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
raving	rave	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Dilaudid	Dilaudid	NN	B-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
consult	consult	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
EGD	EGD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBN	B-VP	O
gastroparesis	gastroparesis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
consult	consult	NN	I-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
emptying	empty	VBG	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
mildly	mildly	RB	I-NP	O
delayed	delay	VBN	I-NP	O
emptying	emptying	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
persistent	persistent	JJ	B-NP	I-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
following	follow	VBG	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
could	could	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
clear	clear	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Familial	Familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
transplant	transplant	NN	I-NP	O
and	and	CC	I-NP	O
AICD	AICD	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Tricuspid	Tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CellCept	CellCept	NN	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Neoral	Neoral	JJ	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

NovoLog	NovoLog	NNP	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Cartia	Cartia	NNP	B-NP	O
XT	XT	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Methotrexate	Methotrexate	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
weekly	weekly	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pravastatin	Pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Rocaltrol	Rocaltrol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
daily	daily	RB	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.3	0.3	CD	I-NP	O
mg	mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
,	,	,	I-VP	O
use	use	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADJP	O
unemployed	unemployed	JJ	I-ADJP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
with	with	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
83	83	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
136/91	136/91	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
lying	lie	VBG	I-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
comfortable	comfortable	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
without	without	IN	B-PP	O
thrush	thrush	NN	B-NP	O
,	,	,	O	O
exudates	exudate	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	JJ	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
AND	AND	CC	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Chemistries	Chemistry	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
83	83	CD	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
:	:	:	O	O
AST	AST	NN	B-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
21	21	CD	I-NP	I-DNA
,	,	,	O	O
amylase	amylase	NN	B-NP	O
57	57	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
bilirubin	bilirubin	NN	B-NP	O
0.7	0.7	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
232	232	CD	I-NP	I-protein
,	,	,	O	O
lipase	lipase	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
1.8	1.8	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
9.3	9.3	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
4.6	4.6	CD	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
0.644	0.644	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
9.9	9.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
44	44	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
236	236	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Coagulation	Coagulation	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
6.4	6.4	CD	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-ADJP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Ventral	Ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
containing	contain	VBG	B-VP	O
nonobstructive	nonobstructive	JJ	B-NP	O
transverse	transverse	JJ	I-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Nonspecific	Nonspecific	JJ	B-NP	O
low-attenuation	low-attenuation	NN	I-NP	O
segment	segment	NN	I-NP	O
VII	VII	CD	I-NP	O
hepatic	hepatic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
remains	remain	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	O
postcontrast	postcontrast	NN	I-NP	O
:	:	:	O	O
Oral	Oral	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
remains	remain	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
possibility	possibility	NN	B-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
atony	atony	NN	I-NP	O
versus	versus	IN	B-PP	O
outlet	outlet	NN	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

EGD	EGD	NN	B-NP	O
:	:	:	O	O
Hypomotility	Hypomotility	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
,	,	,	O	O
biopsies	biopsy	NNS	B-NP	O
taken	take	VBN	B-VP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
pylorus	pylorus	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
duodenum	duodenum	NN	I-NP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	O
post-EGD	post-EGD	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
free	free	JJ	I-NP	O
air	air	NN	I-NP	O
or	or	CC	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

Gastric	Gastric	JJ	B-NP	O
emptying	empty	VBG	I-NP	O
study	study	NN	I-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
delayed	delay	VBN	I-NP	O
emptying	emptying	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
and	and	CC	I-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
Following	Follow	VBG	B-VP	O
several	several	JJ	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
consultations	consultation	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gastroenterologist	gastroenterologist	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
surgeons	surgeon	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
gastroparesis	gastroparesis	NN	B-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
and	and	CC	I-NP	O
CT	CT	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
and	and	CC	I-NP	O
KUB	KUB	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
continued	continue	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
spiking	spike	VBG	I-VP	O
fevers	fever	NNS	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
distended	distended	JJ	I-NP	O
gallbladder	gallbladder	NN	I-NP	O
with	with	IN	B-PP	O
circumferential	circumferential	JJ	B-NP	O
wall	wall	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
stranding	stranding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pericholecystic	pericholecystic	JJ	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
represented	represent	VBD	B-VP	O
acute	acute	JJ	B-NP	O
acalculous	acalculous	JJ	I-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
reconsulted	reconsulte	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exploratory	exploratory	JJ	I-NP	O
laparoscopy	laparoscopy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
for	for	IN	B-PP	O
gangrenous	gangrenous	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
perioperative	perioperative	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
,	,	,	O	O
Levaquin	Levaquin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-NP	O
post	post	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
with	with	IN	B-PP	O
advancement	advancement	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
4/14/2006	4/14/2006	CD	B-NP	O
after	after	IN	B-PP	O
six	six	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Levaquin	Levaquin	NNP	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
drain	drain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
following	follow	VBG	B-VP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
on	on	IN	B-PP	O
4/14/2006	4/14/2006	CD	B-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
the	the	DT	B-NP	O
pulling	pulling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drain	drain	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
leakage	leakage	NN	B-NP	O
of	of	IN	B-PP	O
green-tinged	green-tinged	JJ	B-NP	O
serous	serous	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
abscess	abscess	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ERCP	ERCP	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
cystic	cystic	JJ	I-NP	B-protein
duct	duct	NN	I-NP	I-protein
stump	stump	NN	I-NP	I-protein
bile	bile	NN	I-NP	I-protein
leak	leak	NN	I-NP	I-protein
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
sphincterotomy	sphincterotomy	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
Levaquin	Levaquin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
bile	bile	NN	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
lower-dose	lower-dose	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
CellCept	CellCept	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	O	O
restarted	restart	VBN	B-VP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
got	get	VBD	B-VP	O
stress-dose	stress-dose	JJ	B-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
his	his	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
tapered	taper	VBN	I-VP	O
to	to	TO	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
fluid	fluid	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
got	get	VBD	B-VP	O
100	100	CD	B-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
times	time	NNS	I-NP	O
several	several	JJ	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
restarted	restart	VBD	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
euvolemia	euvolemia	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Cartia	Cartia	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
contribution	contribution	NN	B-NP	O
to	to	TO	B-PP	O
gastroparesis	gastroparesis	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
torsemide	torsemide	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
:	:	:	O	O
Following	Follow	VBG	B-VP	O
his	his	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	B-protein
developed	develop	VBD	B-VP	I-protein
bilateral	bilateral	JJ	B-NP	I-protein
elbow	elbow	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-VP	O
gout	gout	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
rheumatology	rheumatology	NN	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
left	left	JJ	I-NP	O
elbow	elbow	NN	I-NP	O
tap	tap	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
return	return	VB	I-VP	O
any	any	DT	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
several	several	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
was	be	VBD	B-VP	O
slowed	slow	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
gout	gout	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
elbow	elbow	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Phlebitis	Phlebitis	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
developed	develop	VBD	B-VP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
phlebitis	phlebitis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
infiltrating	infiltrate	VBG	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
arm	arm	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
by	by	IN	B-PP	O
them	them	PRP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Magdefrau	Magdefrau	NNP	I-NP	O
from	from	IN	B-PP	O
general	general	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
800-336-8213	800-336-8213	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
staples	staple	NNS	I-NP	O
removed	remove	VBN	B-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Vinion	Vinion	NNP	I-NP	O
from	from	IN	B-PP	O
gastroenterology	gastroenterology	NN	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
stents	stent	NNS	I-NP	O
removed	remove	VBN	B-VP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
is	be	VBZ	B-VP	O
dosed	dose	VBN	I-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Rocaltrol	Rocaltrol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Caltrate	Caltrate	NNP	B-NP	O
600	600	CD	I-NP	O
plus	plus	CC	O	O
D	D	NN	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.3	0.3	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neoral	Neoral	JJ	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Cartia	Cartia	NNP	B-NP	O
XT	XT	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Methotrexate	Methotrexate	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
weekly	weekly	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

CellCept	CellCept	NN	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Pravastatin	Pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Compazine	Compazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Levaquin	Levaquin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
daily	daily	JJ	I-NP	O
x5	x5	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
x15	x15	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Dilaudid	Dilaudid	VBD	B-VP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
x5	x5	CD	B-NP	O
days	day	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-6608485	8-6608485	CD	B-NP	O
HFFocus	HFFocus	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Jerrod	Jerrod	NNP	B-NP	O
Casgrove	Casgrove	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Nawa	Nawa	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Division	Division	NNP	I-NP	O
Rovti	Rovti	NNP	I-NP	O
St	St	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Damion	Damion	NNP	B-NP	O
Dolecki	Dolecki	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Sibicaolkux	Sibicaolkux	NNP	I-NP	O
Flint	Flint	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
YATTAW	YATTAW	NNP	B-NP	O
,	,	,	O	O
RICH	RICH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JAKOWICH	JAKOWICH	NN	B-NP	O
,	,	,	O	O
LAURENCE	LAURENCE	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
3524633	3524633	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
2/5/06	2/5/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/5/06	2/5/06	CD	B-NP	O

